Date published: 2025-12-18

001 800-1338-3838

SCBT Portrait Logo
Seach Input

Lefty 억제제

Lefty inhibitors belong to a distinct class of chemical compounds known for their pivotal role in regulating embryonic development and cell differentiation. These inhibitors are closely associated with the transforming growth factor-beta (TGF-β) superfamily of signaling molecules. To understand Lefty inhibitors, it's essential to appreciate their role within the intricate process of embryogenesis. During early development, Lefty inhibitors play a fundamental role in establishing the body plan of an organism. They are known for their function in maintaining symmetry and axis formation, a critical step in the early stages of embryonic development. Lefty inhibitors act as antagonists to certain signaling pathways within the TGF-β superfamily, exerting their influence by interfering with the signaling molecules involved. Specifically, they counteract the activity of Nodal, an important TGF-β member, which plays a key role in specifying the left-right axis in vertebrates. By doing so, Lefty inhibitors help ensure that the developing embryo forms with appropriate bilateral symmetry, preventing developmental abnormalities and ensuring the proper organization of vital organs.

Lefty inhibitors can be broadly classified into two isoforms: Lefty-1 and Lefty-2. Both isoforms exhibit similar mechanisms of action, working as negative regulators by binding to Nodal and inhibiting its signaling. This function is crucial for maintaining the balance of the Nodal pathway, preventing excessive or inappropriate signaling that could lead to developmental defects. Lefty inhibitors are a prime example of the delicate checks and balances that govern embryonic development. Their presence ensures the precise orchestration of signaling pathways, guaranteeing that an organism's body plan and symmetry are established correctly during its early stages of development. Understanding the mechanisms of Lefty inhibitors is not only essential for developmental biology but also holds potential implications for various fields of science and medicine, shedding light on the intricacies of cell signaling and differentiation.

더보기

Items 11 to 15 of 15 total

디스플레이 라벨:

제품명CAS #카탈로그 번호 수량가격引用RATING

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

라파티닙은 티로신 키나아제를 억제하여 HER2 양성 유방 세포의 성장과 확산을 방해하는 이중 EGFR 및 HER2 억제제입니다.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$115.00
$415.00
11
(1)

베무라페닙은 BRAF V600E 돌연변이를 특이적으로 억제하여 이 특정 돌연변이를 가진 흑색종 세포의 통제되지 않은 증식을 중단시킵니다.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

레고라페닙은 혈관 신생 수용체, 기질 키나제 및 종양 생성 키나제를 표적으로 하는 다중 키나제 억제제로, 성장과 혈관 신생을 조절하는 데 도움이 됩니다.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

오시머티닙은 비소세포폐암(NSCLC) 환자의 내성을 극복하기 위해 EGFR 티로신 키나제 억제제로, EGFR T790M 돌연변이를 표적으로 삼도록 설계되었습니다.

5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine

1032900-25-6sc-505041
1 mg
$230.00
(0)

세리티닙은 ALK 또는 ROS1 유전자 재배열이 있는 비소세포폐암(NSCLC) 연구에서 특히 연구된 ALK 및 ROS1 키나아제를 억제하여 종양 성장을 차단합니다.